Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...

Further optimization of the receptor blocker Researchers have since further optimized the substance, making it even more effective while also increasing its duration of effect for suitability as a ...

The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response. The study findings have been published in the journal Signal Transduction and Targeted Therapy.

Valsartan is an angiotensin receptor blocker (“ARB”) that prevents angiotensin II from binding to its receptor, thereby reducing the blood-vessel-constricting effects of angiotensin II ...

Angiotensin-converting enzyme (ACE) inhibitors are oral medications that lower blood pressure. They are used to treat a variety of heart-related conditions including high blood pressure, coronary ...

and inhibitors of the renin-angiotensin system (ACE inhibitors and angiotensin-II receptor blockers). Lipid-lowering drugs included statins, fibrates and ezetimibe, and antiplatelet drugs aspirin and ...

Many people diagnosed with hypertension are prescribed angiotensin ... ACE-1 inhibitors (ACEIs)—and/or angiotensin receptor blockers (ARBs), which act on the renin-angiotensin (RAS) pathway.

Amvuttra Gains Approval for Transthyretin Amyloid Cardiomyopathy Arbli (losartan potassium oral suspension) Angiotensin II receptor blocker For the treatment of hypertension, to lower blood pressure ...

In contrast, ARBs would be expected to inhibit the biologic effects of angiotensin II more completely than ACE inhibitors, since they block the pathway more distally at the level of the receptor ...

Before receiving a kidney transplant, patients with autosomal dominant polycystic kidney disease often undergo a nephrectomy. But there hasn’t been clear guidance on who’s a good candidate ...